Document
type: Class

4687711
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: PROSPECTIVE PHASE II STUDY ON 5-days AZACITIDINE (5d-AZA) FOR TREATMENT OF SYMPTOMATIC AND/OR ERYTHROPOIETIN UNRESPONSIVE PATIENTS WITH LOW/INT-1 RISK MYELODYSPLASTIC SYNDROMES.

4687710
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: PROSPECTIVE PHASE II STUDY ON 5-days AZACITIDINE (5d-AZA) FOR TREATMENT OF SYMPTOMATIC AND/OR ERYTHROPOIETIN UNRESPONSIVE PATIENTS WITH LOW/INT-1 RISK MYELODYSPLASTIC SYNDROMES.

Academic Article
type: Class

Continuant
type: Class

Inglese
type: Language

Entity
type: Class

Generically Dependent Continuant
type: Class

individual
rights: termsOfUse
date: 2026-08-24T17:44:47
publisher: PROSPECTIVE PHASE II STUDY ON 5-days AZACITIDINE (5d-AZA) FOR TREATMENT OF SYMPTOMATIC AND/OR ERYTHROPOIETIN UNRESPONSIVE PATIENTS WITH LOW/INT-1 RISK MYELODYSPLASTIC SYNDROMES.
type: Document
label: RDF description of PROSPECTIVE PHASE II STUDY ON 5-days AZACITIDINE (5d-AZA) FOR TREATMENT OF SYMPTOMATIC AND/OR ERYTHROPOIETIN UNRESPONSIVE PATIENTS WITH LOW/INT-1 RISK MYELODYSPLASTIC SYNDROMES. - http://irises.unibs.it/resource/item/39953

PROSPECTIVE PHASE II STUDY ON 5-days AZACITIDINE (5d-AZA) FOR TREATMENT OF SYMPTOMATIC AND/OR ERYTHROPOIETIN UNRESPONSIVE PATIENTS WITH LOW/INT-1 RISK MYELODYSPLASTIC SYNDROMES.
type: Document
type: Article
type: Generically Dependent Continuant
language: Inglese
type: Continuant
type: Entity
type: Thing
most specific type: Academic Article
related by: 4687710
type: Information Content Entity
related by: 4687711
type: Academic Article

Article
type: Class

Information Content Entity
type: Class